-
1ανά Gentles, Lauren E, Kehoe, Leanne P, Crawford, Katharine D, Lacombe, Kirsten, Dickerson, Jane, Yuan, Joanna H, Schuler, Susanna L, Nyanseor, Sankan, Saydah, Sharon, Midgley, Claire, Pringle, Kimberly, Bloom, Jesse, Englund, Janet A“…We measured neutralizing Ab using an in-house pseudoneutralization assay and anti-N binding Ab using the Abbott Architect assay. RESULTS: Of 32 children enrolled between April 2020 and January 2021, 27 had no underlying immunocompromised state and 25 of these 27 children had symptomatic disease. …”
Έκδοση 2021
Λήψη πλήρους κειμένου
Λήψη πλήρους κειμένου
Online Άρθρο Κείμενο -
2ανά LaCourse, Sylvia, Kachikis, Alisa, Kinderknecht, Kelsey L, Galang, Romeo R, Zapata, Lauren B, Yamamoto, Krissy M, Salerno, Carol C, Greninger, Alexander L, Englund, Janet A, Drake, Alison“…METHODS: Pregnant people were screened for SARS-CoV-2 IgG during antenatal care or delivery in Seattle, Washington with Abbott Architect chemiluminescent immunoassay which provides quantitative index (positive ≥1.4). …”
Έκδοση 2021
Λήψη πλήρους κειμένου
Λήψη πλήρους κειμένου
Online Άρθρο Κείμενο -
3ανά LaCourse, Sylvia M, Aurelio, Morgan C, Escudero, Jaclyn N, Ellington, Sascha R, Zapata, Lauren B, Snead, Margaret C, Yamamoto, Krissy, Salerno, Carol C, Greninger, Alexander L, Kachikis, Alisa B, Englund, Janet A, Drake, Alison L“…Baseline, 1, 2, 3, 6, and 12 months, and delivery samples were tested for anti-N (index ≥ 1.4 positive) and anti-S (≥ 50 AU/mL positive) IgG Ab by Abbott Architect. Kaplan-Meier methods were used to measure Ab response duration. …”
Έκδοση 2022
Λήψη πλήρους κειμένου
Λήψη πλήρους κειμένου
Online Άρθρο Κείμενο -
4ανά LaCourse, Sylvia M, Wetzler, Erica A, Aurelio, Morgan C, Escudero, Jaclyn N, Selke, Stacy, Greninger, Alex L, Goecker, Erin, Barnes, Sarina R, Arnould, Isabel S, Pérez-Osorio, Ailyn C, Kachikis, Alisa B, Englund, Janet A, Drake, Alison L“…Blood samples collected in pregnancy, delivery/birth, 0-< 3 and 3-6 months postpartum were tested for anti-S+ IgG by Abbott Architect (positive: ≥50 AU/mL) and neutralizing antibodies (serum dilution inhibited infection by 50% [ND50 heat] ≥20 and R(2) ≥0.9). …”
Έκδοση 2023
Λήψη πλήρους κειμένου
Λήψη πλήρους κειμένου
Online Άρθρο Κείμενο